a. Textbooks
Arief. (2012). Hepatitis Virus; Buku Ajar Gastroenterologi - Hepatologi. Jakarta: IDAI.
Departemen Kesehatan Republik Indonesia. (2007). Pharmaceutical Care untuk Penyakit Hati. Direktorat Bina Farmasi Komunitas Dan Klinik, 11–18
Dunkelberg, JC. (2014). Hepatitis B and C in Pregnancy, in Review and Recommendation for Care. J Perinatal; 34; 882-891
Noer, S. (2007). Buku Ajar Ilmu Penyakit Hati . Jakarta: Jaya Abadi.
Ranuh, et al. (2011). Imunisasi Upaya Pencegahan Primer. Pedoman Imunisasi Di Indonesia. 4th Edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. P.2-9
Sanityoso. (2009). Hepatitis Virus Akut; Buku Ajar Ilmu Penyakit dalam Jilid I Edisi V. Jakarta: Universitas Indonesia.
Sastrosoewignjo, T. (2020). Buku Mikrobiologi Kedokteran. Jakarta: Bina Rupa Aksara
Wija, I. B. (2021). Hep-B pada Anak. 1-10.
b. From Journals:
Burdiek RA. (2003). Patterns of Hepatitis B Prevalence and Seroconversion in Hemodialysis Units from Three Continents; the DOPPS. Kidney Int; 63: 2222-2229.
Centers for Disease Control and Prevention. (2001). Recommendation for Preventing Transmission of infection among Chronic Hemodialysis Patients. MMWR Recomm Rep; 50: 1-43.
Centers for Disease Control, Hepatitis B Virus; a Comprehensive Strategy for Eliminating Transmission in United States through Universal Childhood Vaccination; Recommendations of the Immunization Practices Advisory Committee (ACIP), MMWR 1991;40: 1-25.
Chang, (1997). Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children. Taiwan Childhood Hepatoma Study Group. N. Engl J Med, 226: 1855-9.
Gitlin N. (1997) Hepatitis B; Diagnosis, Prevention, and Treatment. Clin Chem; 43: 1500-1506.
Goldstein ST, (2002). et al. Incidence and Risk Factors for Acute Hepatitis B in the United States, J. Infect Dis 2002; 185:713-9.
Healy. (2001). Is there a Need for National Policy? Irish Med J ;94:111-2.
Hudu, et al. (2022): Hepatitis B Therapeutic Vaccine: A Patent Review. Pharmaceuticals, 15, 1542. https://doi.org/10.3390/ ph15121542.
Homenta, Novie. et al. (2017). Hepatitis B Seroprotect ion in Children Aged 10 – 15 Years After Completion of Basic Hepatitis B Immunizations. Paediatrica Indonesiana. Vol.57, No.2(2017). p. 76-83; doi: http://dx.doi.org/10.14238/pi57.2.2017.76-83.
Lee WM. (1997). Hepatitis B Virus Infection. N Engl J Med; 337; 1733-1745.
Magdzik. (2000). Hepatitis B Epidemology in Poland. Central and Eastern Europe and the Newly Independent States. Vaccine:18:S13-S16.
McNaughton, et al. (2020). Hepatitis B Virus Sero Epidemiology Data for Africa: Modelling Intervention Strategies based on a Systematic Review and Meta Analysis. PlosMed 17(4): e1003068. . https://doi.org/10.1371/journal.pmed.1003068.
Milich D. Liang TJ. (2003). Exploring the Biological Basis of Hepatitis B e-antigen in Hepatitis B Virus Infection. Hepatology: 38; 1075-1086.
Miriam J. Alter. Epidemology of Hepatitis B in Europe and Worldwide. Journal of Hepatology. 2003: 39; S64-S69.
Naishida. (2013). Genome Wide Association Study Reveals Host Genetic Factors for Liver Disease. J Clin Transl Hepatol; 1: 45-50.
Peter Medawar, et al. (2021). Therapeutic Vaccination for Treatment of Chronic Hepatitis B. Clinical & Experimental Immunology. DOI: 10.1111/cei.13614
Popa (2002). Use of Surveillance for Acute Hepatitis among Children to Assess the Impact of Routine Infant Hepatitis B Vaccination Programs in Romania. Atlanta: International Medical Press; p. 261-2.
Steenberg, Van. (1998). Evaluation of Hepatitis B Antenatal Screening and Neonatal Immunization Program in Amsterdam, Vaccine 2001: 20:7-11
Timo, et al. (2021). Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine A Phase 3 Randomized Clinical Trial. JAMA Network Open ;4(10):e2128652. doi:10.1001/jamanetworkopen.2021.28652.
Tsukakoshi, et al. (2015). Hepatitis B Serologic Survey and Review of Immunization Records of Children, Adolescents and Adults in Fiji, 2008-2009. Virologi Journal; 12;36. Doi 10.1186/s12985-015-0267-7.
Rahnavardi. (2008). Hepatitis C in Hemodialysis Patients; Current Global Magnitude, Natural History, Diagnostic Difficulties and Preventing Measures. Am J Nephrol; 28: 628-640.
Villa, Da. Rationale for the Infant and Adolescent Vaccination Program in Italy. Vaccine 2000:18:S31-4.
Villa G, Da. et al. (2002). Pilot Project of Universal Hep-B Vaccination of Newborns in Hyperendemic Area: Results After 17 Years. Atlanta: International Medical Press; p. 258-60.
Yano Y, Utsumi T. Lusida MI, Hayashi Y. (2015). Hepatitis B Virus Infection in Indonesia. World J Gatsoenterol; 21: 10714-1072.
c. From Internet:
Departemen Kesehatan RI. (2014). Cakupan Imunisasi Hepatitis B Pada Bayi di Indonesia. [Cited 2014 July 28]. Available from: http://bankdata.depkes.go.id/Profil/Indo04
US Department of Health and Human Services. (2021). Hepatitis B Basic Information. Reviewed August. https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.html
US Centers for Disease Control and Prevention. (2016). Viral Hepatitis Surveillance: United States, https://cdc.gov/hepatitis/statistics/2016surveillance/pdfs/2016HepSurveillanceRpt.pdf
World Health Organization. (2020). Hepatitis. Retrieved from www.who.int/health-topics/hepatitis.
Arief. (2012). Hepatitis Virus; Buku Ajar Gastroenterologi - Hepatologi. Jakarta: IDAI.
Departemen Kesehatan Republik Indonesia. (2007). Pharmaceutical Care untuk Penyakit Hati. Direktorat Bina Farmasi Komunitas Dan Klinik, 11–18
Dunkelberg, JC. (2014). Hepatitis B and C in Pregnancy, in Review and Recommendation for Care. J Perinatal; 34; 882-891
Noer, S. (2007). Buku Ajar Ilmu Penyakit Hati . Jakarta: Jaya Abadi.
Ranuh, et al. (2011). Imunisasi Upaya Pencegahan Primer. Pedoman Imunisasi Di Indonesia. 4th Edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. P.2-9
Sanityoso. (2009). Hepatitis Virus Akut; Buku Ajar Ilmu Penyakit dalam Jilid I Edisi V. Jakarta: Universitas Indonesia.
Sastrosoewignjo, T. (2020). Buku Mikrobiologi Kedokteran. Jakarta: Bina Rupa Aksara
Wija, I. B. (2021). Hep-B pada Anak. 1-10.
b. From Journals:
Burdiek RA. (2003). Patterns of Hepatitis B Prevalence and Seroconversion in Hemodialysis Units from Three Continents; the DOPPS. Kidney Int; 63: 2222-2229.
Centers for Disease Control and Prevention. (2001). Recommendation for Preventing Transmission of infection among Chronic Hemodialysis Patients. MMWR Recomm Rep; 50: 1-43.
Centers for Disease Control, Hepatitis B Virus; a Comprehensive Strategy for Eliminating Transmission in United States through Universal Childhood Vaccination; Recommendations of the Immunization Practices Advisory Committee (ACIP), MMWR 1991;40: 1-25.
Chang, (1997). Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children. Taiwan Childhood Hepatoma Study Group. N. Engl J Med, 226: 1855-9.
Gitlin N. (1997) Hepatitis B; Diagnosis, Prevention, and Treatment. Clin Chem; 43: 1500-1506.
Goldstein ST, (2002). et al. Incidence and Risk Factors for Acute Hepatitis B in the United States, J. Infect Dis 2002; 185:713-9.
Healy. (2001). Is there a Need for National Policy? Irish Med J ;94:111-2.
Hudu, et al. (2022): Hepatitis B Therapeutic Vaccine: A Patent Review. Pharmaceuticals, 15, 1542. https://doi.org/10.3390/ ph15121542.
Homenta, Novie. et al. (2017). Hepatitis B Seroprotect ion in Children Aged 10 – 15 Years After Completion of Basic Hepatitis B Immunizations. Paediatrica Indonesiana. Vol.57, No.2(2017). p. 76-83; doi: http://dx.doi.org/10.14238/pi57.2.2017.76-83.
Lee WM. (1997). Hepatitis B Virus Infection. N Engl J Med; 337; 1733-1745.
Magdzik. (2000). Hepatitis B Epidemology in Poland. Central and Eastern Europe and the Newly Independent States. Vaccine:18:S13-S16.
McNaughton, et al. (2020). Hepatitis B Virus Sero Epidemiology Data for Africa: Modelling Intervention Strategies based on a Systematic Review and Meta Analysis. PlosMed 17(4): e1003068. . https://doi.org/10.1371/journal.pmed.1003068.
Milich D. Liang TJ. (2003). Exploring the Biological Basis of Hepatitis B e-antigen in Hepatitis B Virus Infection. Hepatology: 38; 1075-1086.
Miriam J. Alter. Epidemology of Hepatitis B in Europe and Worldwide. Journal of Hepatology. 2003: 39; S64-S69.
Naishida. (2013). Genome Wide Association Study Reveals Host Genetic Factors for Liver Disease. J Clin Transl Hepatol; 1: 45-50.
Peter Medawar, et al. (2021). Therapeutic Vaccination for Treatment of Chronic Hepatitis B. Clinical & Experimental Immunology. DOI: 10.1111/cei.13614
Popa (2002). Use of Surveillance for Acute Hepatitis among Children to Assess the Impact of Routine Infant Hepatitis B Vaccination Programs in Romania. Atlanta: International Medical Press; p. 261-2.
Steenberg, Van. (1998). Evaluation of Hepatitis B Antenatal Screening and Neonatal Immunization Program in Amsterdam, Vaccine 2001: 20:7-11
Timo, et al. (2021). Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine A Phase 3 Randomized Clinical Trial. JAMA Network Open ;4(10):e2128652. doi:10.1001/jamanetworkopen.2021.28652.
Tsukakoshi, et al. (2015). Hepatitis B Serologic Survey and Review of Immunization Records of Children, Adolescents and Adults in Fiji, 2008-2009. Virologi Journal; 12;36. Doi 10.1186/s12985-015-0267-7.
Rahnavardi. (2008). Hepatitis C in Hemodialysis Patients; Current Global Magnitude, Natural History, Diagnostic Difficulties and Preventing Measures. Am J Nephrol; 28: 628-640.
Villa, Da. Rationale for the Infant and Adolescent Vaccination Program in Italy. Vaccine 2000:18:S31-4.
Villa G, Da. et al. (2002). Pilot Project of Universal Hep-B Vaccination of Newborns in Hyperendemic Area: Results After 17 Years. Atlanta: International Medical Press; p. 258-60.
Yano Y, Utsumi T. Lusida MI, Hayashi Y. (2015). Hepatitis B Virus Infection in Indonesia. World J Gatsoenterol; 21: 10714-1072.
c. From Internet:
Departemen Kesehatan RI. (2014). Cakupan Imunisasi Hepatitis B Pada Bayi di Indonesia. [Cited 2014 July 28]. Available from: http://bankdata.depkes.go.id/Profil/Indo04
US Department of Health and Human Services. (2021). Hepatitis B Basic Information. Reviewed August. https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.html
US Centers for Disease Control and Prevention. (2016). Viral Hepatitis Surveillance: United States, https://cdc.gov/hepatitis/statistics/2016surveillance/pdfs/2016HepSurveillanceRpt.pdf
World Health Organization. (2020). Hepatitis. Retrieved from www.who.int/health-topics/hepatitis.
- Abstract viewed - 73 times
- PDF downloaded - 56 times
Downloads
Download data is not yet available.
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright
© Jurnal Agregasi : Aksi Reformasi Government dalam Demokrasi, 2023
Affiliations
Elsa Silvia
Institut Teknologi Bandung
Defri Rizaldy
Sekolah Farmasi, Institut Teknologi Bandung
How to Cite
Silvia, E., & Rizaldy, D. (2023). Kepuasan Masyarakat terhadap Layanan Pemerintah dalam Menurunkan Prevalensi Penyakit Hep-B pada Anak Usia 0-12 Tahun di Indonesia. Jurnal Agregasi : Aksi Reformasi Government Dalam Demokrasi, 11(2), 161-173. https://doi.org/10.34010/agregasi.v11i2.9640
Kepuasan Masyarakat terhadap Layanan Pemerintah dalam Menurunkan Prevalensi Penyakit Hep-B pada Anak Usia 0-12 Tahun di Indonesia
Public Satisfaction of Government Services in Reducing the Prevalence of Hep-B Disease for Children 0-12 Years in Indonesia
Vol 11 No 2 (2023)
Abstract
This research taken from a substantial and urgent need for the Indonesian especially for children under 0-12 years in Indonesia who still has limit knowledge about Hep-B prevalence. The government has work harder to give health education and awareness in reducing the prevalence of hep-B disease for children 0-12 years in Indonesia. Therefore, the purpose of this study is to see how good the communication strategy is conducted by government of Indonesia and how about the public satisfaction about its services. This study used quantitative method by using an observative, documentative and questionnaire for 220 respondents from several districts in Indonesia as the tools of collecting data. This research concluded that: (a) public services in terms of health education and awareness campaigns in reducing the prevalence of hep-B in children aged 0-12 years was good and satisfying, b) the factors that most influence in increase in the prevalence of Hep-B in children aged 0-12 years are mother-to-child transmission: can occur during pregnancy, childbirth, or breastfeeding and is a common mode of transmission in areas with high prevalence of hep-B and lack of screening, c). what the government can do as a public service in reducing the prevalence of Hep-B in children aged 0-12 years in Indonesia is health education and awareness of hep-B campaign by several ways, such as school-based education, community-based education, mass media campaign, and health worker education.